Xufei Yang

509 total citations · 1 hit paper
11 papers, 368 citations indexed

About

Xufei Yang is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Rheumatology. According to data from OpenAlex, Xufei Yang has authored 11 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Immunology and 4 papers in Rheumatology. Recurrent topics in Xufei Yang's work include Atherosclerosis and Cardiovascular Diseases (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Cardiac Fibrosis and Remodeling (2 papers). Xufei Yang is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Cardiac Fibrosis and Remodeling (2 papers). Xufei Yang collaborates with scholars based in China and United States. Xufei Yang's co-authors include Peng Gao, Yongtai Liu, Hongzhi Xie, Yechen Han, Zhujun Shen, Yuanqiang Zhang, Wei Wu, Peipei Chen, Lianfeng Chen and Haiyu Pang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of the American College of Cardiology and Frontiers in Immunology.

In The Last Decade

Xufei Yang

10 papers receiving 363 citations

Hit Papers

Effect of metformin on all-cause and cardiovascular morta... 2019 2026 2021 2023 2019 50 100 150 200

Peers

Xufei Yang
Xufei Yang
Citations per year, relative to Xufei Yang Xufei Yang (= 1×) peers Chihiro Horimai

Countries citing papers authored by Xufei Yang

Since Specialization
Citations

This map shows the geographic impact of Xufei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufei Yang more than expected).

Fields of papers citing papers by Xufei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufei Yang. The network helps show where Xufei Yang may publish in the future.

Co-authorship network of co-authors of Xufei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xufei Yang. A scholar is included among the top collaborators of Xufei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufei Yang. Xufei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhang, Yang, Yicong Ye, Xiaoqiang Tang, et al.. (2022). CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure. The Journal of Experimental Medicine. 219(8). 26 indexed citations
2.
Pang, Haiyu, Tian Du, Xufei Yang, et al.. (2021). Establishing a Risk Prediction Model for Atherosclerosis in Systemic Lupus Erythematosus. Frontiers in Immunology. 12. 622216–622216. 13 indexed citations
3.
Chen, Peipei, Ying Xiao, Lianfeng Chen, et al.. (2020). Intracellular calcium current disorder and disease phenotype in OBSCN mutant iPSC-based cardiomyocytes in arrhythmogenic right ventricular cardiomyopathy. Theranostics. 10(24). 11215–11229. 23 indexed citations
4.
Qian, Hao, Peng Gao, Ran Tian, et al.. (2020). Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study. Journal of Cardiothoracic and Vascular Anesthesia. 35(3). 846–853. 11 indexed citations
5.
Long, Bo, et al.. (2020). Long noncoding RNA ASB16-AS1 inhibits adrenocortical carcinoma cell growth by promoting ubiquitination of RNA-binding protein HuR. Cell Death and Disease. 11(11). 995–995. 21 indexed citations
6.
Du, Tian, Haiyu Pang, Yicong Ye, et al.. (2020). Reduction in SLEDAI is associated with improved arterial stiffness in systemic lupus erythematosus. Medicine. 99(47). e23184–e23184. 5 indexed citations
8.
Han, Yechen, Hongzhi Xie, Yongtai Liu, et al.. (2019). Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis. Cardiovascular Diabetology. 18(1). 96–96. 246 indexed citations breakdown →
9.
Chen, Peipei, Yuexin Chen, Wei Wu, et al.. (2019). Identification and validation of four hub genes involved in the plaque deterioration of atherosclerosis. Aging. 11(16). 6469–6489. 14 indexed citations
10.
Zhang, Yang, Yicong Ye, Xufei Yang, Xinglin Yang, & Yuanqiang Zhang. (2018). GW29-e1858 Chemokine CCL17 acts as a new biomarker and therapeutic target in pathological cardiac hypertrophy. Journal of the American College of Cardiology. 72(16). C75–C75. 1 indexed citations
11.
Yang, Xufei, et al.. (2018). Relationship between Neutrophil-to-Lymphocyte Ratio and Pulse Wave Velocity in Young Patients with Systemic Lupus Erythematosus. Chinese Medical Journal. 131(1). 10–15. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026